ABQURE
Live / Registered — Registered (as of 11 Jul 2023)
What this means for you
Registered since 11 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90779841
- Registration number
- 7102820
- Mark type
- Stylized text
- Filed
- 17 Jun 2021
- Published for opposition
- 14 Feb 2023
- Registered
- 11 Jul 2023
- Attorney of record
- Julianne Abelman
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing, namely, reagents for medical use; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases
- Class 042 — Scientific and technological services: Research, product development and consultancy in the field of biotechnology, biologic pharmaceutical preparations, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
- Class 044 — Medical, beauty and agricultural services: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
Owner
- UNIQURE BIOPHARMA B.V., AMSTERDAM, NL
- uniQure IP B.V., Amsterdam, NL
- uniQure IP B.V., Amsterdam, NL
- uniQure IP B.V., Amsterdam, NL
Prosecution history
- 11 Jun 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 04 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Jun 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 04 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 04 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 04 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2023 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 14 Apr 2023 — NOTICE OF ALLOWANCE CANCELLED
- 01 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Apr 2023 — TEAS DELETE 1(B) BASIS RECEIVED
- 11 Apr 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT